Potential drug targets for Mycobacterium avium defined by radiometric drug-inhibitor combination techniques
Authors:
Open Access
- 1 October 1994
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 38 (10) , 2287-2295
Abstract
Previously established radiometric techniques were used to assess the effectiveness of combined antimicrobial drug-inhibitory drug (drug-inhibitor) treatment on two clinical isolates of the Mycobacterium avium complex representing three colony variants: smooth opaque (dome) (SmO), smooth transparent (SmT), and rough (Rg). All variants were identified as members of the M. avium complex; however, only the SmT colony type of strain 373 possessed characteristic serovar-specific glycopeptidolipid (GPL) antigens. MICs, determined radiometrically, of drugs with the potential to inhibit the biosynthesis of GPL antigens or other cell envelope constituents were similar for all strains. These drugs included cerulenin, N-carbamyl-DL-phenylalanine, N-carbamyl-L-isoleucine, trans-cinnamic acid, ethambutol, 1-fluoro-1-deoxy-beta-D-glucose, 2-deoxy-D-glucose, and m-fluoro-phenylalanine. The MICs of the antimicrobial drugs amikacin, sparfloxacin, and clarithromycin varied, but overall the MICs for the SmO variant were the lowest. Radiometric assessment of drug-inhibitor combinations by using established x/y determinations revealed enhanced activity when either ethambutol or cerulenin were used in combination with all antimicrobial agents for all variants except the Rg variant of strain 424, for which ethambutol was not effective. Enhanced activity with amino acid analogs was observed with the Rg colony variants of strains 373 and 424. Two potential sites for drug targeting were identified: fatty acid synthesis, for all strains assayed, and peptide biosynthesis, particularly for Rg colony variants that possess previously identified phenylalanine-containing lipopeptides as potential targets for future drug development.Keywords
This publication has 24 references indexed in Scilit:
- Molecular basis of colony morphology in Mycobacterium aviumResearch in Microbiology, 1994
- Comparative effects ofMycobacterium aviumglycopeptidolipid and lipopeptide fragment on the function and ultrastructure of mononuclear cellsClinical and Experimental Immunology, 1993
- Spectrum of drugs against atypical mycobacteria: How valid is the current practice of drug susceptibility testing and the choice of drugs?Zentralblatt für Bakteriologie, 1992
- Contributing factors of pathogenesis in the Mycobacterium avium complexResearch in Microbiology, 1991
- Inhibition of glycopeptidolipid synthesis resulting from treatment of Mycobacterium avium with 2-deoxy-D-glucoseResearch in Microbiology, 1991
- Inhibition of synthesis of arabinogalactan by ethambutol in Mycobacterium smegmatisAntimicrobial Agents and Chemotherapy, 1989
- In-vitro synergistic activity between ethambutol and fluorinated qoinolones against Mycobacterium avium complexJournal of Antimicrobial Chemotherapy, 1989
- Radiolabelling of Mycobacterium avium Oligosaccharide Determinant and Use in Macrophage StudiesMicrobiology, 1989
- Drug susceptibility testing in tuberculosis: A comparison of the proportion methods using Lowenstein-Jensen, middlebrook 7H10 and 7H11 agar media and a radiometric methodResearch in Microbiology, 1989
- Basis for Lack of Drug Susceptibility of Atypical MycobacteriaClinical Infectious Diseases, 1981